Ultralife Stock Analysis

ULBI Stock  USD 8.73  0.32  3.80%   
Ultralife is undervalued with Real Value of 9.96 and Target Price of 12.0. The main objective of Ultralife stock analysis is to determine its intrinsic value, which is an estimate of what Ultralife is worth, separate from its market price. There are two main types of Ultralife's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Ultralife's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Ultralife's stock to identify patterns and trends that may indicate its future price movements.
The Ultralife stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Ultralife is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Ultralife Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ultralife's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ultralife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.

Ultralife Stock Analysis Notes

About 69.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.17. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Ultralife had not issued any dividends in recent years. Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company was incorporated in 1990 and is headquartered in Newark, New York. Ultralife Corp operates under Electrical Equipment Parts classification in the United States and is traded on NASDAQ Exchange. It employs 560 people. For more information please call Michael Manna at 315 332 7100 or visit https://www.ultralifecorporation.com.

Ultralife Quarterly Total Revenue

44.55 Million

Ultralife Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ultralife's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ultralife or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ultralife had very high historical volatility over the last 90 days
Ultralife is unlikely to experience financial distress in the next 2 years
About 69.0% of the company outstanding shares are owned by institutional investors
Latest headline from news.google.com: Ultralife Scheduled to Post Earnings on Thursday - MarketBeat

Ultralife Upcoming and Recent Events

Earnings reports are used by Ultralife to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ultralife previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Ultralife Largest EPS Surprises

Earnings surprises can significantly impact Ultralife's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-07-28
2022-06-300.010.030.02200 
2022-02-03
2021-12-31-0.04-0.06-0.0250 
2021-04-29
2021-03-310.060.04-0.0233 
View All Earnings Estimates

Ultralife Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ultralife is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ultralife backward and forwards among themselves. Ultralife's institutional investor refers to the entity that pools money to purchase Ultralife's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Two Sigma Advisers, Llc2023-12-31
85.6 K
Arrowstreet Capital Limited Partnership2023-12-31
82.1 K
First Trust Advisors L.p.2023-12-31
81.7 K
Connor Clark & Lunn Inv Mgmt Ltd2023-12-31
67.1 K
Jpmorgan Chase & Co2023-12-31
66.3 K
Clarivest Asset Management Llc2023-12-31
64.7 K
Millennium Management Llc2023-12-31
54.1 K
Susquehanna International Group, Llp2023-12-31
54.1 K
State Street Corporation2023-12-31
49.7 K
Visionary Wealth Advisors2023-12-31
1.1 M
Dimensional Fund Advisors, Inc.2023-12-31
931 K
Note, although Ultralife's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ultralife Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 138.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ultralife's market, we take the total number of its shares issued and multiply it by Ultralife's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Ultralife Profitablity

Ultralife's profitability indicators refer to fundamental financial ratios that showcase Ultralife's ability to generate income relative to its revenue or operating costs. If, let's say, Ultralife is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Ultralife's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Ultralife's profitability requires more research than a typical breakdown of Ultralife's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.06  0.06 
Return On Capital Employed 0.06  0.06 
Return On Assets 0.04  0.04 
Return On Equity 0.06  0.06 

Management Efficiency

Ultralife has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0593 %, meaning that it created $0.0593 on every $100 dollars invested by stockholders. Ultralife's management efficiency ratios could be used to measure how well Ultralife manages its routine affairs as well as how well it operates its assets and liabilities. The Ultralife's current Return On Tangible Assets is estimated to increase to 0.06. The Ultralife's current Return On Capital Employed is estimated to increase to 0.06. As of now, Ultralife's Return On Tangible Assets are increasing as compared to previous years. The Ultralife's current Return On Assets is estimated to increase to 0.04, while Total Assets are projected to decrease to under 98.2 M.
Last ReportedProjected for Next Year
Book Value Per Share 7.73  4.13 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 4.49  4.46 
Enterprise Value Over EBITDA 9.67  9.19 
Price Book Value Ratio 0.88  0.84 
Enterprise Value Multiple 9.67  9.19 
Price Fair Value 0.88  0.84 
Enterprise Value116.5 M76.6 M
The analysis of Ultralife's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Ultralife's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Ultralife Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.248

Technical Drivers

As of the 25th of April, Ultralife has the Semi Deviation of 3.0, risk adjusted performance of 0.0582, and Coefficient Of Variation of 1256.02. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Ultralife, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have analyzed nineteen technical drivers for Ultralife, which can be compared to its competition. Please validate Ultralife jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Ultralife is priced more or less accurately, providing market reflects its prevalent price of 8.73 per share. Given that Ultralife has jensen alpha of 0.1672, we advise you to double-check Ultralife's current market performance to make sure the company can sustain itself at a future point.

Ultralife Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ultralife middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ultralife. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Ultralife Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ultralife insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ultralife's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ultralife insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ultralife Predictive Daily Indicators

Ultralife intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ultralife stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ultralife Corporate Filings

F4
19th of April 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
29th of March 2024
Other Reports
ViewVerify
10K
21st of March 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
F4
13th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
15th of February 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
14th of February 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
9th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
29th of December 2023
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Ultralife Forecast Models

Ultralife's time-series forecasting models are one of many Ultralife's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ultralife's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ultralife Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ultralife prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ultralife shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ultralife. By using and applying Ultralife Stock analysis, traders can create a robust methodology for identifying Ultralife entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.06  0.06 
Operating Profit Margin 0.06  0.06 
Net Profit Margin 0.05  0.05 
Gross Profit Margin 0.24  0.16 

Current Ultralife Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ultralife analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ultralife analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
12.0Strong Buy1Odds
Ultralife current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Ultralife analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ultralife stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ultralife, talking to its executives and customers, or listening to Ultralife conference calls.
Ultralife Analyst Advice Details

Ultralife Stock Analysis Indicators

Ultralife stock analysis indicators help investors evaluate how Ultralife stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ultralife shares will generate the highest return on investment. By understating and applying Ultralife stock analysis, traders can identify Ultralife position entry and exit signals to maximize returns.
Begin Period Cash Flow5.7 M
Long Term Debt23.6 M
Common Stock Shares Outstanding16.2 M
Total Stockholder Equity125.3 M
Tax Provision1.5 M
Quarterly Earnings Growth Y O Y5.898
Property Plant And Equipment Net24.7 M
Cash And Short Term Investments10.3 M
Cash10.3 M
Accounts Payable11.3 M
Net Debt18.9 M
50 Day M A9.054
Total Current Liabilities23.7 M
Other Operating Expenses149.2 M
Non Current Assets Total88.1 M
Forward Price Earnings16.1812
Non Currrent Assets Other-15 M
Stock Based Compensation528 K
When determining whether Ultralife offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ultralife's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ultralife Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ultralife Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ultralife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.
Note that the Ultralife information on this page should be used as a complementary analysis to other Ultralife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Ultralife Stock analysis

When running Ultralife's price analysis, check to measure Ultralife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultralife is operating at the current time. Most of Ultralife's value examination focuses on studying past and present price action to predict the probability of Ultralife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultralife's price. Additionally, you may evaluate how the addition of Ultralife to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Ultralife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultralife. If investors know Ultralife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultralife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.898
Earnings Share
0.44
Revenue Per Share
9.785
Quarterly Revenue Growth
0.234
Return On Assets
0.0342
The market value of Ultralife is measured differently than its book value, which is the value of Ultralife that is recorded on the company's balance sheet. Investors also form their own opinion of Ultralife's value that differs from its market value or its book value, called intrinsic value, which is Ultralife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultralife's market value can be influenced by many factors that don't directly affect Ultralife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultralife's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultralife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultralife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.